J Diabetes. 2011 Dec;3(4):261-4. doi: 10.1111/j.1753-0407.2011.00144.x.
Type 2 diabetes (T2D) and obesity are both complex and chronic medical disorders, each with an escalating worldwide prevalence. When obesity is severe, and/or available medical therapies fail to control the diabetes, bariatric surgery becomes a cost-effective therapy for T2D. When there are other major comorbidities and cardiovascular risk, the option of bariatric surgery becomes even more worthy of consideration. National guidelines for bariatric surgery need to be developed and implemented for people with T2D. With this in mind, the International Diabetes Federation convened a multidisciplinary working group to develop a position statement. The key recommendations cover describing those eligible for surgery and who should be prioritized, incorporating bariatric surgery into T2D treatment algorithms, performing surgery in centers with multidisciplinary teams that are experienced in the management of both obesity and diabetes, and developing bariatric surgery registries and reporting standards.
2 型糖尿病（T2D）和肥胖症都是复杂且慢性的医学疾病，二者在全球的患病率都在不断上升。当肥胖症严重且/或可用的医疗疗法无法控制糖尿病时，减重手术成为 T2D 的一种具有成本效益的疗法。当存在其他主要合并症和心血管风险时，减重手术的选择更值得考虑。需要为 T2D 患者制定和实施减重手术的国家指南。有鉴于此，国际糖尿病联合会召集了一个多学科工作组来制定一份立场声明。主要建议涵盖了描述适合手术的人群和应优先考虑的人群，将减重手术纳入 T2D 治疗算法，在具有多学科团队的中心进行手术，这些团队在肥胖症和糖尿病的管理方面经验丰富，以及开发减重手术登记处和报告标准。
